- UroToday Home
- Recent Abstracts
- Urologic Oncology
Renal Cancer
Sunitinib in kidney cancer: 10 years of experience and development
December 20, 2016
Causal inference in obesity research
December 19, 2016
Updated European Association of Urology Guidelines Regarding Adjuvant Therapy for Renal Cell Carcinoma
December 18, 2016
Sorafenib dose escalation in treatment-naïve patients with metastatic renal cell carcinoma: a non-randomised, open-label, Phase 2b study.
December 18, 2016
Adjuvant treatment for renal cell carcinoma: do we finally have a major breakthrough?
December 12, 2016
MicroRNA profiling in clear cell renal cell carcinoma tissues potentially links tumorigenesis and recurrence with obesity
December 9, 2016
Tumor Infiltrating Mast Cells (TIMs) Confers a Marked Survival Advantage in Nonmetastatic Clear-Cell Renal Cell Carcinoma
December 9, 2016
Genetic predisposition to kidney cancer
December 8, 2016
Clear Cell Type A and B Molecular Subtypes in Metastatic Clear Cell Renal Cell Carcinoma: Tumor Heterogeneity and Aggressiveness
December 8, 2016
Partial Versus Radical Nephrectomy for T1-T2 Renal Masses in the Elderly: Comparison of Complications, Renal Function, and Oncologic Outcomes
December 7, 2016
Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of renal cell carcinoma
December 7, 2016
Sunitinib in the treatment of metastatic renal cell carcinoma
December 6, 2016
Cabozantinib in the treatment of advanced renal cell carcinoma: clinical trial evidence and experience
December 6, 2016
Obesity and Kidney Cancer
December 5, 2016
Excess weight as a risk factor common to many cancer sites: words of caution when interpreting meta-analytic evidence
December 5, 2016
Safety, Tolerability and Pharmacokinetics of Oral Administration of GW786034 in Patients with Solid Tumors
December 4, 2016